| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00000542-197609000-00011 |
| P698 | PubMed publication ID | 786079 |
| P2093 | author name string | B. A. Hitt | |
| R. I. Mazze | |||
| J. M. Baden | |||
| R. S. Wharton | |||
| M. Brinkenhoff | |||
| V. F. Simmon | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | volatile anaesthetic | Q126282515 |
| P304 | page(s) | 311-318 | |
| P577 | publication date | 1976-09-01 | |
| P1433 | published in | Anesthesiology | Q2012635 |
| P1476 | title | Mutagenicity of volatile anesthetics: halothane | |
| P478 | volume | 45 |
| Q34664249 | Bioactivation and covalent binding of halothane to liver macromolecules |
| Q50182054 | Chromosome and sister-chromatid exchange analysis in peripheral lymphocytes, and mutagenicity of urine in anesthesiology personnel |
| Q34664418 | Detection of mutagenic activity in the urines of anesthesiologists: a preliminary report |
| Q40081968 | Mutagenic effects of inhalational anesthetics |
| Q34664465 | Mutagenicity of the halogenated olefin, 2-bromo-2-chloro-1,1-difluoroethylene, a presumed metabolite of the inhalation anesthetic halothane |
| Q34313486 | Occupational exposure to volatile anaesthetics: epidemiology and approaches to reducing the problem |
| Q39266979 | Pharmacology and Toxicology of Halogenated Anesthetics |
| Q39229119 | Role of biotransformation in the toxicity of inhalation anesthetics |
| Q51858158 | The effects of halothane on the DNase I activity in an isolated enzyme preparation and in the DNase I-G actin complex |
| Q34282785 | TheSalmonellaMutagenicity Assay: The Stethoscope of Genetic Toxicology for the 21st Century |
Search more.